The Best of 2022: FDA Approvals and the Breakthroughs That Enabled Them
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
This year, the American Association for Cancer Research (AACR) launched a series of Patient Advocate Forums, virtual conversations featuring...
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but...
Researchers, physicians, patients, and other stakeholders convened in San Antonio, Texas, December 6-10 for the annual San Antonio Breast...
By Kaleem Zaidi, PhDAACR Executive Office The year 2022 marked significant progress against cancer, thanks to advances in cancer...
You’re feeling sluggish. You eat a banana. You feel better. We all know that a calorie-rich snack can provide...
By Steven Grossman, MD, PhD Pancreatic cancer is an outlier among cancers, fiercely resisting almost every scientific advance researchers...
As COVID-19 cases and death rates fall, and in-person activities resume, cancer centers once again fill their beds with...
By Nicholas Warren, PhD Today, the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology...
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...